| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Recoverin | 6.73e-08 | 13 | 60 | 4 | IPR028846 | |
| Domain | EF-hand_7 | 7.78e-06 | 85 | 60 | 5 | PF13499 | |
| Domain | T-box_assoc | 1.01e-05 | 2 | 60 | 2 | PF16176 | |
| Domain | T-box_assoc | 1.01e-05 | 2 | 60 | 2 | IPR032385 | |
| Domain | EF_HAND_2 | 9.61e-05 | 231 | 60 | 6 | PS50222 | |
| Domain | EF_hand_dom | 9.85e-05 | 232 | 60 | 6 | IPR002048 | |
| Domain | EF-hand_1 | 1.27e-04 | 152 | 60 | 5 | PF00036 | |
| Domain | EFh | 1.53e-04 | 158 | 60 | 5 | SM00054 | |
| Domain | EF_Hand_1_Ca_BS | 2.46e-04 | 175 | 60 | 5 | IPR018247 | |
| Domain | EF_HAND_1 | 4.96e-04 | 204 | 60 | 5 | PS00018 | |
| Domain | TIL | 6.56e-04 | 12 | 60 | 2 | PF01826 | |
| Domain | C8 | 6.56e-04 | 12 | 60 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 7.74e-04 | 13 | 60 | 2 | IPR014853 | |
| Domain | C8 | 7.74e-04 | 13 | 60 | 2 | SM00832 | |
| Domain | TIL_dom | 9.01e-04 | 14 | 60 | 2 | IPR002919 | |
| Domain | VWD | 1.18e-03 | 16 | 60 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.18e-03 | 16 | 60 | 2 | IPR001846 | |
| Domain | VWFD | 1.18e-03 | 16 | 60 | 2 | PS51233 | |
| Domain | VWD | 1.18e-03 | 16 | 60 | 2 | PF00094 | |
| Domain | TF_T-box | 1.34e-03 | 17 | 60 | 2 | IPR001699 | |
| Domain | TBOX | 1.34e-03 | 17 | 60 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 1.34e-03 | 17 | 60 | 2 | IPR018186 | |
| Domain | - | 1.34e-03 | 17 | 60 | 2 | 2.60.40.820 | |
| Domain | TBOX_3 | 1.34e-03 | 17 | 60 | 2 | PS50252 | |
| Domain | T-box | 1.34e-03 | 17 | 60 | 2 | PF00907 | |
| Domain | TBOX_1 | 1.34e-03 | 17 | 60 | 2 | PS01283 | |
| Domain | TBOX_2 | 1.34e-03 | 17 | 60 | 2 | PS01264 | |
| Domain | - | 1.50e-03 | 261 | 60 | 5 | 1.10.238.10 | |
| Domain | VWC_out | 1.68e-03 | 19 | 60 | 2 | SM00215 | |
| Domain | EF-hand-dom_pair | 2.27e-03 | 287 | 60 | 5 | IPR011992 | |
| Domain | EF-hand_8 | 5.33e-03 | 34 | 60 | 2 | PF13833 | |
| Pubmed | Neurogenesis requires TopBP1 to prevent catastrophic replicative DNA damage in early progenitors. | 9.47e-08 | 24 | 62 | 4 | 22522401 | |
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 35977029 | ||
| Pubmed | 6.42e-07 | 10 | 62 | 3 | 11964161 | ||
| Pubmed | The EHEC-host interactome reveals novel targets for the translocated intimin receptor. | 6.42e-07 | 10 | 62 | 3 | 25519916 | |
| Pubmed | 1.17e-06 | 12 | 62 | 3 | 24695699 | ||
| Pubmed | 2.42e-06 | 15 | 62 | 3 | 26290337 | ||
| Pubmed | 2.97e-06 | 16 | 62 | 3 | 32321712 | ||
| Pubmed | Stalled replication forks within heterochromatin require ATRX for protection. | 2.97e-06 | 16 | 62 | 3 | 27171262 | |
| Pubmed | DNA-PKcs, ATM, and ATR Interplay Maintains Genome Integrity during Neurogenesis. | 2.97e-06 | 16 | 62 | 3 | 28123024 | |
| Pubmed | Neurocalcin family: a novel calcium-binding protein abundant in bovine central nervous system. | 3.13e-06 | 2 | 62 | 2 | 8387172 | |
| Pubmed | Functional contribution of Ca2+ and Mg2+ to the intermolecular interaction of visinin-like proteins. | 3.13e-06 | 2 | 62 | 2 | 16703469 | |
| Pubmed | Are DNA repair factors promising biomarkers for personalized therapy in gastric cancer? | 3.13e-06 | 2 | 62 | 2 | 22894650 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 10520747 | ||
| Pubmed | Regulation of P2X2 receptors by the neuronal calcium sensor VILIP1. | 3.13e-06 | 2 | 62 | 2 | 18922787 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 25019684 | ||
| Pubmed | DNA single-strand break-induced DNA damage response causes heart failure. | 3.13e-06 | 2 | 62 | 2 | 28436431 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 12445467 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 10974533 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 10851344 | ||
| Pubmed | Loss of Dmrt5 Affects the Formation of the Subplate and Early Corticogenesis. | 5.12e-06 | 19 | 62 | 3 | 31845734 | |
| Pubmed | Snf2h Drives Chromatin Remodeling to Prime Upper Layer Cortical Neuron Development. | 7.01e-06 | 21 | 62 | 3 | 31680852 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 11836243 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 10857751 | ||
| Pubmed | Developmental expression of the T-box transcription factor T-bet/Tbx21 during mouse embryogenesis. | 9.37e-06 | 3 | 62 | 2 | 12128215 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 26088318 | ||
| Pubmed | A novel mammalian T-box-containing gene, Tbr2, expressed in mouse developing brain. | 9.37e-06 | 3 | 62 | 2 | 10407135 | |
| Pubmed | Expression of the T-box gene Eomesodermin during early mouse development. | 9.37e-06 | 3 | 62 | 2 | 10330500 | |
| Pubmed | Mapping and expression analysis of the mouse ortholog of Xenopus Eomesodermin. | 9.37e-06 | 3 | 62 | 2 | 10330501 | |
| Pubmed | Expression pattern of the Tbr2 (Eomesodermin) gene during mouse and chick brain development. | 9.37e-06 | 3 | 62 | 2 | 10473127 | |
| Pubmed | ATR maintains select progenitors during nervous system development. | 1.21e-05 | 25 | 62 | 3 | 22266795 | |
| Pubmed | NPC1 MAPK8IP1 UBE4A VSNL1 GLS FBXO11 NBEA ZNF224 ATM ZBED5 FN3K | 1.51e-05 | 1285 | 62 | 11 | 35914814 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 32008040 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 21637298 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 36796357 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 16621079 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 16520463 | ||
| Pubmed | Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK. | 1.87e-05 | 4 | 62 | 2 | 19851285 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 30317028 | ||
| Pubmed | WNT signalling control by KDM5C during development affects cognition. | 3.12e-05 | 5 | 62 | 2 | 38383780 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 27050514 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 23622239 | ||
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 19286843 | ||
| Pubmed | Tbt-1, a new T-box transcription factor induced in activated Th1 and CD8+ T cells. | 3.12e-05 | 5 | 62 | 2 | 10970091 | |
| Pubmed | Requirement for DNA ligase IV during embryonic neuronal development. | 3.12e-05 | 5 | 62 | 2 | 21734301 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 14739275 | ||
| Pubmed | Neurogenesis and neuronal migration in the forebrain of the TorsinA knockout mouse embryo. | 3.12e-05 | 5 | 62 | 2 | 23018676 | |
| Pubmed | The Protein Tyrosine Phosphatase Receptor Delta Regulates Developmental Neurogenesis. | 3.12e-05 | 5 | 62 | 2 | 31914388 | |
| Pubmed | Delayed maturation and migration of excitatory neurons in the juvenile mouse paralaminar amygdala. | 4.35e-05 | 38 | 62 | 3 | 38086370 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 18829510 | ||
| Pubmed | Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome. | 4.67e-05 | 6 | 62 | 2 | 19056494 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 32888487 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 16966185 | ||
| Pubmed | Eomesodermin is required for mouse trophoblast development and mesoderm formation. | 4.67e-05 | 6 | 62 | 2 | 10716450 | |
| Pubmed | Cocaine alters BDNF expression and neuronal migration in the embryonic mouse forebrain. | 4.67e-05 | 6 | 62 | 2 | 21940433 | |
| Pubmed | Cytosine-5 RNA Methylation Regulates Neural Stem Cell Differentiation and Motility. | 4.67e-05 | 6 | 62 | 2 | 28041877 | |
| Pubmed | Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. | 4.67e-05 | 6 | 62 | 2 | 20696378 | |
| Pubmed | Prdm8 regulates the morphological transition at multipolar phase during neocortical development. | 4.67e-05 | 6 | 62 | 2 | 24489718 | |
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 15878096 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 30210296 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 20170971 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 22537351 | ||
| Pubmed | Pax6 regulates Tbr1 and Tbr2 expressions in olfactory bulb mitral cells. | 6.53e-05 | 7 | 62 | 2 | 23353076 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 33042990 | ||
| Pubmed | CoupTFI interacts with retinoic acid signaling during cortical development. | 6.53e-05 | 7 | 62 | 2 | 23472160 | |
| Pubmed | Zic2 Controls the Migration of Specific Neuronal Populations in the Developing Forebrain. | 6.53e-05 | 7 | 62 | 2 | 26269635 | |
| Pubmed | Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome. | 6.53e-05 | 7 | 62 | 2 | 26961948 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 27845622 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 22956851 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 21864333 | ||
| Pubmed | Heterogeneous nuclear ribonucleoprotein U (HNRNPU) safeguards the developing mouse cortex. | 7.75e-05 | 46 | 62 | 3 | 35864088 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 21491541 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 24726360 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 34931379 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 9503012 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 18084280 | ||
| Pubmed | Regional differences in mitral cell development in mouse olfactory bulb. | 8.69e-05 | 8 | 62 | 2 | 30864157 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 22892427 | ||
| Pubmed | A Novel and Multivalent Role of Pax6 in Cerebellar Development. | 8.69e-05 | 8 | 62 | 2 | 27581449 | |
| Pubmed | TRIM32 Deficiency Impairs the Generation of Pyramidal Neurons in Developing Cerebral Cortex. | 8.69e-05 | 8 | 62 | 2 | 35159260 | |
| Pubmed | Upregulation of MicroRNA miR-9 Is Associated with Microcephaly and Zika Virus Infection in Mice. | 8.69e-05 | 8 | 62 | 2 | 30264295 | |
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 36843845 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 35090564 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 22164283 | ||
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 25972180 | ||
| Pubmed | Rbm8a haploinsufficiency disrupts embryonic cortical development resulting in microcephaly. | 1.12e-04 | 9 | 62 | 2 | 25948253 | |
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 35135854 | ||
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 35604347 | ||
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 33488348 | ||
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 29530878 | ||
| Pubmed | Dual functions of ASCIZ in the DNA base damage response and pulmonary organogenesis. | 1.12e-04 | 9 | 62 | 2 | 20975950 | |
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 18065723 | ||
| Pubmed | ATRX is required for maintenance of the neuroprogenitor cell pool in the embryonic mouse brain. | 1.12e-04 | 9 | 62 | 2 | 25395668 | |
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 38636614 | ||
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 24953933 | ||
| Pubmed | 1.12e-04 | 9 | 62 | 2 | 31319858 | ||
| Pubmed | Tcf4 is required for correct brain development during embryogenesis. | 1.12e-04 | 9 | 62 | 2 | 32474139 | |
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 23175820 | ||
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 38487272 | ||
| Pubmed | Ephrin-B2 paces neuronal production in the developing neocortex. | 1.39e-04 | 10 | 62 | 2 | 32404061 | |
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 39095712 | ||
| Interaction | MAP3K11 interactions | 1.12e-06 | 60 | 62 | 5 | int:MAP3K11 | |
| Interaction | DGUOK interactions | 8.87e-06 | 91 | 62 | 5 | int:DGUOK | |
| Interaction | HPCA interactions | 1.01e-05 | 44 | 62 | 4 | int:HPCA | |
| Interaction | NCALD interactions | 3.26e-05 | 59 | 62 | 4 | int:NCALD | |
| Interaction | C1QTNF2 interactions | 3.96e-05 | 62 | 62 | 4 | int:C1QTNF2 | |
| Interaction | NUFIP1 interactions | 6.62e-05 | 138 | 62 | 5 | int:NUFIP1 | |
| Interaction | LITAF interactions | 9.29e-05 | 77 | 62 | 4 | int:LITAF | |
| Cytoband | 10p12.31 | 4.07e-04 | 22 | 62 | 2 | 10p12.31 | |
| GeneFamily | EF-hand domain containing | 8.03e-06 | 219 | 40 | 6 | 863 | |
| GeneFamily | T-boxes | 7.14e-04 | 18 | 40 | 2 | 766 | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.61e-06 | 189 | 62 | 5 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.69e-06 | 195 | 62 | 5 | 574354ef4bcefeb9856b65d19bb92e2cffe5dc7a | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer|World / Primary Cells by Cluster | 8.08e-06 | 197 | 62 | 5 | 41e823b14697827f657b13adb3afa581bd91a9cb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.28e-06 | 198 | 62 | 5 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.28e-06 | 198 | 62 | 5 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.28e-06 | 198 | 62 | 5 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.28e-06 | 198 | 62 | 5 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-cortical_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 8.28e-06 | 198 | 62 | 5 | d81f35c0066558ff96dd06f58fca72cd82e681e8 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK_activated|COVID-19_Severe / Disease group, lineage and cell class | 8.49e-06 | 199 | 62 | 5 | edf5f80b4c299e6bf462675f2cd3329d86c923d8 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated|COVID-19_Severe / Disease, condition lineage and cell class | 8.70e-06 | 200 | 62 | 5 | 6a77f9643646bafc1157bf1fc1e4c614860ee642 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-cortical_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 8.70e-06 | 200 | 62 | 5 | 0cb0755a101ec655359d051d6a8807408d727c55 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-05 | 161 | 62 | 4 | 69f5e759c0925daa37e0177a9cc3154842906bf6 | |
| ToppCell | tumor_Lung-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 8.05e-05 | 164 | 62 | 4 | 60fe6bb86afaebd92590135f08f5434ce0d8d73c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 165 | 62 | 4 | 6d8b5669eee9b0903c9260fea707d186c9d7fefa | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-05 | 165 | 62 | 4 | 02cd87dfa2ca40e13455a4b9308477e82f76289b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.03e-04 | 175 | 62 | 4 | 0ed053aa8353c72ff37fee830672704a3ddc7d85 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.03e-04 | 175 | 62 | 4 | 0124a3c4696b39cee8b566e94603d1d3d128bfa5 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-04 | 175 | 62 | 4 | e219b61d6bc078d44ea7d06191d3462654d857a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-04 | 175 | 62 | 4 | bd16c80418bf71127e6f1e50edf83967c9218b42 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-mature_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-04 | 177 | 62 | 4 | 0f2616a81f8fbede77c860b2126e3fa826672da3 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_C|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 178 | 62 | 4 | 7203149864cc8d5ae25329fdbf15c6b73c3d3595 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 179 | 62 | 4 | d96741c5c551e36421b2ad938072ab7d506c3835 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-04 | 180 | 62 | 4 | b7513b9816a9cb9f3caaddb2a9fed0be1c7f9805 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-04 | 180 | 62 | 4 | f96c5be4705e3d338c0393d2885ac8d5beccd6fd | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 180 | 62 | 4 | 5b7d2336ed09d07f6b8dd91c1fa9c5ade633c104 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(INS+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 180 | 62 | 4 | 0c5d9245b8a7cc34ad52522d31559906cda55bdf | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.18e-04 | 181 | 62 | 4 | 9c4f9abb9335da2b07644bca8faff1baa1bb9f5b | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 182 | 62 | 4 | c6172aca2475bf0948a78e39f0dae6388504a915 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-04 | 183 | 62 | 4 | 01ad18f198195ce341bae01a1c8c253cc4607766 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.31e-04 | 186 | 62 | 4 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | IPF-Lymphoid-NK|IPF / Disease state, Lineage and Cell class | 1.39e-04 | 189 | 62 | 4 | d92e880162450f8d01e4b8784eb625275cb8e03e | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 191 | 62 | 4 | 2bd4ba4aaa0f4885079516156b409df527ab22f4 | |
| ToppCell | IPF-Lymphoid-NK|World / Disease state, Lineage and Cell class | 1.45e-04 | 191 | 62 | 4 | f206159b9d5e84cf14a65bfdc008895cec5a8081 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-mature_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.48e-04 | 192 | 62 | 4 | e48bbcb97c113f323ad4db96bd10d593b9206923 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.48e-04 | 192 | 62 | 4 | 35557254738844c27ffcd00f3287fbcc0a4d0f3b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CFuPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.48e-04 | 192 | 62 | 4 | a8841ebd879f1c344ab4246fdef77044170f644d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 193 | 62 | 4 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 193 | 62 | 4 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.51e-04 | 193 | 62 | 4 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.51e-04 | 193 | 62 | 4 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-NK|Int-URO / Disease, Lineage and Cell Type | 1.51e-04 | 193 | 62 | 4 | 5c7942f630fc69374df34ee3602ad973b6ced17a | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type | 1.54e-04 | 194 | 62 | 4 | 36afc4e48d267be3b8aa1e33fad043bcd54c6bc5 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.57e-04 | 195 | 62 | 4 | 609732e83ab7fc3ba7dace66f5a17e46557fd6d1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 195 | 62 | 4 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | Control-Lymphocyte-T_NK-NK|Control / Disease, Lineage and Cell Type | 1.60e-04 | 196 | 62 | 4 | 65838fddc920cdcecefe823f3ce1c95a7e50e82b | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-innate_lymphocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.60e-04 | 196 | 62 | 4 | 2849c8f06518c9523093b86167daea4c0b9eda73 | |
| ToppCell | severe-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.60e-04 | 196 | 62 | 4 | d83acd9abd7b296989b8ae09da63799e6877a149 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.60e-04 | 196 | 62 | 4 | bd251231288c900b23d3a676ceec6ac07d228917 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.63e-04 | 197 | 62 | 4 | 550cce374332c49893bcf4ce4b7dceb7f5fe26aa | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 197 | 62 | 4 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.66e-04 | 198 | 62 | 4 | a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2 | |
| ToppCell | severe_COVID-19-NK|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.66e-04 | 198 | 62 | 4 | 7f51e37516f717e424190e6584f1c74d357e2da4 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.66e-04 | 198 | 62 | 4 | c54da37aa11f82a68e591d563b3db9121d6b498f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-04 | 198 | 62 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|World / disease group, cell group and cell class (v2) | 1.66e-04 | 198 | 62 | 4 | 7a0aac52d785037455e068e1b25de4b2bf0fff79 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.66e-04 | 198 | 62 | 4 | 58d805e827299292750b09c6283fdbe406b75f79 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.66e-04 | 198 | 62 | 4 | 1e43181c13e054570046c7a973ddc1c586e259b0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-04 | 198 | 62 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.66e-04 | 198 | 62 | 4 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.66e-04 | 198 | 62 | 4 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.66e-04 | 198 | 62 | 4 | 90023468f3498548a92d75928f476b4157bde813 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.66e-04 | 198 | 62 | 4 | 76aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c | |
| ToppCell | CV|World / Virus stimulation, Condition and Cluster | 1.66e-04 | 198 | 62 | 4 | 6a28193af35abec5c029129930c2ca6febaafde2 | |
| ToppCell | CD8+_Memory_T_cell-CV|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.66e-04 | 198 | 62 | 4 | 3d1749f5106f0912f4a74615863853949f52c73d | |
| ToppCell | URO-Lymphocyte-T_NK-NK|URO / Disease, Lineage and Cell Type | 1.66e-04 | 198 | 62 | 4 | 2ccff882aafabf041df15b31d9abc50dcbc2696e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.66e-04 | 198 | 62 | 4 | a781fd35a7cda8b7760c2e3ddccaac7aac26c979 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.66e-04 | 198 | 62 | 4 | a0032e3ed259e39324a659490b9d340c5d9ba0fc | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.66e-04 | 198 | 62 | 4 | df399674345c45738d765a8354ea8d1484572c34 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.66e-04 | 198 | 62 | 4 | 5607e36f393cb399fcc2504502498453fd32d96b | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.66e-04 | 198 | 62 | 4 | 60d8d3bbd754ffde41c50013d822667b185a9751 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-gd_T|COVID-19_Mild / Disease group, lineage and cell class | 1.66e-04 | 198 | 62 | 4 | 6aea5d00c417708f05b6d2dfe5a962d80864f8eb | |
| ToppCell | COVID-19_Moderate-NK|World / disease group, cell group and cell class | 1.69e-04 | 199 | 62 | 4 | c41b67b760831c7d5e19fabcc932a056dc560f93 | |
| ToppCell | Transverse-NK_cell|Transverse / Region, Cell class and subclass | 1.69e-04 | 199 | 62 | 4 | 6d5d57addfed3947408b9af7d6aa78aaa3197f94 | |
| ToppCell | Transverse-(0)_NK_cell-(00)_NK|Transverse / shred on region, Cell_type, and subtype | 1.69e-04 | 199 | 62 | 4 | b649375394bc55b8727814283defed711e899e9c | |
| ToppCell | COVID-19_Severe-NK_activated|COVID-19_Severe / disease group, cell group and cell class | 1.69e-04 | 199 | 62 | 4 | bda28d975f4017ec5bded1d3c72310eabc5aac07 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-04 | 199 | 62 | 4 | 26bb93347e6722abd174dfa62cab692ce2b7eb23 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.69e-04 | 199 | 62 | 4 | 0cd3e4e0fba000c996feaf012ff32198e1048c9d | |
| ToppCell | Transverse-NK_cell-NK|Transverse / Region, Cell class and subclass | 1.69e-04 | 199 | 62 | 4 | 418e936d3528b6672ab54f77919588e4ed01a8d2 | |
| ToppCell | Transverse-(0)_NK_cell|Transverse / shred on region, Cell_type, and subtype | 1.69e-04 | 199 | 62 | 4 | 1970a85893b87eca18916df2504c5148fcd9ceb2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.73e-04 | 200 | 62 | 4 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class | 1.73e-04 | 200 | 62 | 4 | 6560753d3df2f87860b52052d4881aa45410f666 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.73e-04 | 200 | 62 | 4 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.73e-04 | 200 | 62 | 4 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon|organoid_Velasco_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.73e-04 | 200 | 62 | 4 | f6d6a2f4e2f51c292dfb97280353a49117798fc6 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | a8b59e6fe04271fef61db911a286b5c48438bb84 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK|Control / Disease, condition lineage and cell class | 1.73e-04 | 200 | 62 | 4 | c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.73e-04 | 200 | 62 | 4 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-NK|URO / Disease, condition lineage and cell class | 1.73e-04 | 200 | 62 | 4 | 741c7bad606c7e4d7db57d89aaf4dcf4232fa82a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Neuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.73e-04 | 200 | 62 | 4 | 6f3fe94107fa2a2ded4888780b36700cce48adb7 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | eda7a1d822e8663510662bc0ca34eaccc88d71ca | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.73e-04 | 200 | 62 | 4 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.73e-04 | 200 | 62 | 4 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-NK|Int-URO / Disease, condition lineage and cell class | 1.73e-04 | 200 | 62 | 4 | 3ae0f3dc4f6c9e0315155de80967134b2c1b3364 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-NK|Leuk-UTI / Disease, condition lineage and cell class | 1.73e-04 | 200 | 62 | 4 | bb37fed4872e71f413ae7c4aa12586fa31075334 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-NK_CD56bright|Int-URO / Disease, condition lineage and cell class | 1.73e-04 | 200 | 62 | 4 | 776b6590e21dbd80b6679433727070e06bf01f0f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Neuron|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.73e-04 | 200 | 62 | 4 | b5019b9d48f32cffd4645a5c0f3e0ac504ea8019 | |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; HL60; HG-U133A | 9.59e-07 | 197 | 61 | 7 | 1780_DN | |
| Disease | senile cataract (is_implicated_in) | 2.06e-04 | 11 | 58 | 2 | DOID:9669 (is_implicated_in) | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 2.47e-04 | 12 | 58 | 2 | DOID:3319 (is_marker_for) | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 1.49e-03 | 29 | 58 | 2 | cv:C5779548 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.61e-03 | 139 | 58 | 3 | DOID:3908 (is_implicated_in) | |
| Disease | stomach cancer (is_marker_for) | 2.77e-03 | 142 | 58 | 3 | DOID:10534 (is_marker_for) | |
| Disease | renal cell carcinoma | 3.11e-03 | 42 | 58 | 2 | EFO_0000681 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DHNPFAKGFRDNYDS | 446 | O95936 | |
| GPRLYFHSSFNCFDF | 531 | Q15878 | |
| AAFPAGFQHEAFPSY | 276 | Q9BUH8 | |
| QFHAASPLHYAKFFD | 291 | A6NE02 | |
| YFFSFTAGKAPHKSL | 76 | Q9BXJ3 | |
| VASSVPNFKHFGFYR | 286 | Q9BWV3 | |
| GNHERFETTYFKKFP | 531 | Q9NR19 | |
| YFFQESFRAPNHTKF | 136 | P51164 | |
| HSFYFPGQFAFSKAL | 146 | Q99969 | |
| FPYGDASKFAEHVFR | 56 | P84074 | |
| PQKNFFAHYFTLGSK | 316 | P29074 | |
| YDFSGQFAFHVGLPA | 466 | O94925 | |
| FPYGDASKFAQHAFR | 56 | Q9UM19 | |
| VFRNAHFDYSPAGLA | 316 | Q9UBI9 | |
| YFGFITKHPADHRFA | 656 | Q9UQF2 | |
| SAGLFAFYHDKDGNP | 281 | Q96KR4 | |
| AFYHDKDGNPLTSRF | 286 | Q96KR4 | |
| FGRRYFPPKFQDAHF | 1491 | Q8IY21 | |
| FGDKIFYPHNFFDQF | 226 | P07098 | |
| YKGQCSFFAVFHPHF | 151 | Q8TDV5 | |
| FPYGDASKFAEHVFR | 56 | P37235 | |
| SGPAKDFYQREFDFF | 191 | Q8N8J0 | |
| SFHYKTFDGDVFRFP | 86 | P98088 | |
| PFSFIDFYRKQRGHN | 411 | Q96MM6 | |
| ANKYPIFFFGTHETA | 41 | Q9Y3E1 | |
| EKEYFDQHFGPFFRT | 391 | O15118 | |
| KHVPASSGYNFRFAK | 291 | Q9UBL9 | |
| SSFHYFQGRFELSGK | 21 | P0CF75 | |
| GAHKRYRPNDFSAFQ | 2786 | Q13315 | |
| KPGFAEHFYSNPARY | 246 | Q86XK2 | |
| EFFDHKNGTPFSCFY | 176 | Q9NPA1 | |
| VFFYEFQHRPSSFAK | 436 | Q6UWW8 | |
| YSHRAQEFGVKSAFP | 876 | Q5VT52 | |
| FPYGDASKFAEHVFR | 56 | P61601 | |
| HTAAFSYFQKAAARG | 261 | Q14154 | |
| YKAVVLAANHFGRFF | 201 | Q13423 | |
| SANYFQEKFFPGHES | 46 | Q969X6 | |
| YGFNEGHSFRRQYKP | 81 | Q9P015 | |
| FVSNYAKARFHPGAG | 436 | Q16650 | |
| FKDFHEGAINFGPTY | 766 | O15056 | |
| QIFGAYATHPFKFSD | 841 | Q8NI08 | |
| GTNFLKDHRFGSYAA | 331 | Q13393 | |
| HHFQDFRFKTYAPVA | 126 | O60331 | |
| NGAYLSIKAFAFRHF | 516 | Q9NTG1 | |
| FGHSFYKETPAAFPD | 1636 | Q8NFP9 | |
| MFGGFPRSFFTAYHR | 251 | Q9H479 | |
| FFPQFHAFGLRYCDA | 601 | Q9NZC9 | |
| AARVNLSFDFPFYGH | 156 | Q6UX71 | |
| SGPAKDFYQRGFDFF | 191 | A4QPH2 | |
| FFSFAANGRYSLKVH | 676 | Q9UQC9 | |
| GHYLTFDGFPFDFQT | 1106 | O75443 | |
| FPYGDASKFAQHAFR | 56 | P62760 | |
| FAEGAAFPAYRAPHA | 11 | Q9H2W2 | |
| DNAKALYRAGVAFFH | 106 | Q8N5M4 | |
| NFFFFKHDENLYGPI | 336 | Q6UW63 | |
| FPAHKAVLACAAGYF | 41 | O15060 | |
| SFGFTYFGNRDAPHA | 116 | Q49AG3 | |
| YSKDSPFGLSFVRFH | 136 | P18887 | |
| DFFQGKHFFLYGEFP | 541 | P18887 | |
| FTGDPHQFEQKFNYR | 731 | Q14139 | |
| NGYKPSFSDVSHFDF | 151 | Q9NZL3 | |
| FPDKGYSFVRFNSHE | 246 | P31483 | |
| ECGKAFFYSASFRAH | 311 | P17017 | |
| FGTNAHFVKRPYDAE | 981 | Q5THJ4 |